GLP Watchdog

DudeMeds vs Embody

Neither DudeMeds nor Embody has an FDA warning letter on record. On compounded tirzepatide injection, Embody costs $1,248 less a year at standing rates: $129 a month against $233 a month at DudeMeds. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

DudeMeds / Embody

DudeMeds logo

DudeMeds

6.8/10

Embody logo

Embody

9.3/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
$79/moCompounded semaglutide injection
States
45 states
All 50 states and DC
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit DudeMeds
Visit Embody

Both DudeMeds and Embody are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (DudeMeds 6.8, Embody 9.3). How we are paid

What the record shows

  1. 01

    Neither DudeMeds nor Embody has an FDA warning letter on record.

  2. 02

    Embody names four pharmacies. DudeMeds names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, Embody costs $1,248 less a year at standing rates: $129 a month against $233 a month at DudeMeds. It is one of two products the two sell at comparable terms.

  4. 04

    Only DudeMeds lists a price for brand-name semaglutide pen and brand-name tirzepatide pen. Only Embody lists a price for compounded oral tirzepatide.

  5. 05

    Embody covers five states DudeMeds does not.

  6. 06

    DudeMeds holds you to a prepaid 2- to 4-month kits that auto-renew; Embody states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

DudeMeds

Embody

Compounded semaglutide injection

$179/mo

$2,148 a year

$79/moLower

$948 a year

Compounded tirzepatide injection

$233/mo

$2,796 a year

$129/moLower

$1,548 a year

Brand-name semaglutide pen

$1,585/mo

$19,020 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,350/mo

$16,200 a year

Not sold or not priced
Compounded oral tirzepatide
Not sold or not priced

$329/mo

$3,948 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
No
Yes, stated
Minimum term
Prepaid 2- to 4-month kits that auto-renew
None on the one-month plan; 3-, 6- and 12-month plans are prepaid
Refunds
No refund once a prescription is filled and shipped
No refunds once paid; a partial refund only after a medical disqualification
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. DudeMeds: October 17, 2026. Embody: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for DudeMeds

6.8/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Embody does not price
  • Names no compounding pharmacy
  • Minimum commitment before you can cancel
Visit DudeMeds

The case for Embody

9.3/10
  • $1,200 a year less on compounded semaglutide injection
  • $1,248 a year less on compounded tirzepatide injection
  • Sells compounded oral tirzepatide, which DudeMeds does not price
  • Names its compounding pharmacy
Visit Embody

Scores

DudeMeds 6.8 · Embody 9.3 out of 10. Six weighted parts.

Value25%

6.0A
vs
B
10.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

5.0A
vs
B
9.0

Accessibility10%

9.2A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

DudeMeds vs Embody: questions

Neither DudeMeds nor Embody has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Embody names four pharmacies. DudeMeds names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Embody, by $1,200 a year at standing rates. DudeMeds: $179 a month, about $2,148 a year. Embody: $79 a month, about $948 a year.
DudeMeds has a minimum term (prepaid 2- to 4-month kits that auto-renew). Embody states you can cancel at any time; refunds: no refunds once paid; a partial refund only after a medical disqualification.
Both DudeMeds and Embody are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (DudeMeds 6.8, Embody 9.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks